Targeting the Sweet Spot: New Northwestern Medicine Study Clarifies When Coronary Artery Calcium Scans Deliver Real Clinical Value

Coronary artery calcium (CAC) scans have surged in popularity over the past decade as a fast, accessible, and relatively inexpensive computerized tomography (CT) diagnostic tool designed to peer inside the cardiovascular system and measure calcified plaque buildup within the heart’s blood-supplying arteries. For millions of patients seeking proactive insight into their long-term cardiac health, these scans have often been marketed as a definitive window into future heart disease risk. However, a major new study published on August 26 in the journal JAMA by researchers at Northwestern Medicine reveals that the clinical utility of these scans is far more nuanced than previously understood.

According to the research, adding a coronary artery calcium score to standard risk assessment tools yields only marginal overall benefits for the general population. Instead, the true value of a calcium scan is concentrated within a much narrower slice of patients—specifically, those whose preliminary clinical evaluations land them in a borderline or intermediate risk category. As cardiovascular disease remains the leading cause of death in the United States, accounting for roughly one in every five deaths and impacting approximately 10 percent of American adults aged 30 to 79, optimizing the deployment of diagnostic resources has become a paramount priority for healthcare systems nationwide.

Understanding the Mechanics: PREVENT Versus Calcium Scans

To fully appreciate the implications of the Northwestern Medicine study, it is necessary to examine the two primary risk-stratification methods evaluated by the researchers: the American Heart Association’s PREVENT calculator and the coronary artery calcium scan.

The PREVENT calculator is a sophisticated, non-invasive risk assessment tool that leverages commonly available biometric and demographic health information. Without requiring any advanced imaging, PREVENT evaluates variables such as a patient’s blood pressure, total cholesterol levels, age, sex, and other baseline clinical metrics to estimate their statistical probability of developing cardiovascular disease over a 10-year or 30-year horizon. It represents the frontline of modern preventative cardiology, offering clinicians a rapid, cost-effective way to gauge baseline vulnerability.

In contrast, a coronary artery calcium scan approaches risk assessment from a structural and anatomical perspective. Utilizing a specialized low-dose CT machine, the scan captures cross-sectional images of the chest to detect, visualize, and quantify calcium-containing atherosclerotic plaque inside the coronary arteries. The resulting Agatston score reflects the total burden of calcified plaque; higher scores generally correlate with a steeply elevated risk of suffering a future heart attack or stroke.

For years, many medical professionals advocated for the widespread, routine integration of calcium scans across diverse patient populations, operating under the assumption that visualizing actual arterial disease would universally improve predictive accuracy. The new research challenges this blanket approach, demonstrating that standard algorithms like PREVENT already perform remarkably well on their own for vast segments of the population.

A Decade-Long Investigation Into Real Outcomes

To investigate the incremental value of adding calcium scans to standard clinical calculations, senior author Dr. Nilay Shah and his multidisciplinary team at the Northwestern University Feinberg School of Medicine analyzed comprehensive longitudinal data from the Multi-Ethnic Study of Atherosclerosis (MESA). This landmark, observational cohort study provided a robust foundation for the investigation, encompassing more than 6,000 diverse adult participants between the ages of 45 and 79 who were free of clinical cardiovascular disease at baseline.

At the onset of the study period, every participant underwent a baseline evaluation that generated both a coronary artery calcium score and a PREVENT 10-year cardiovascular risk estimate. The researchers then tracked the health trajectories of these individuals over a rigorous 10-year follow-up period, recording actual clinical events such as non-fatal myocardial infarctions, strokes, and cardiovascular-related deaths.

During the decade of tracking, precisely 6 percent of the study cohort experienced a major cardiovascular event. When the research team evaluated how accurately predictions matched real-world outcomes, the inclusion of calcium scores alongside the PREVENT calculator produced only a modest overall enhancement.

Statistically, the model’s discrimination—a standard metric used to measure how effectively a predictive tool distinguishes between individuals who will experience an event and those who will not—increased only slightly. The C-statistic rose from 0.73 when utilizing the PREVENT calculator alone to 0.75 when coronary artery calcium scores were factored into the equation. For the broad population as a whole, this incremental statistical lift was deemed minimal.

The Pivot Point: Borderline and Intermediate Risk Categories

The narrative of the study shifted dramatically, however, when the researchers disaggregated the data and focused specifically on a targeted subpopulation: individuals whose initial PREVENT scores placed them in the borderline or intermediate risk categories. These are patients initially calculated to have a 3 percent to 9 percent probability of experiencing a cardiovascular event within the next decade.

Within this specific clinical group, the addition of a coronary artery calcium score proved exceptionally valuable. For patients whose baseline risk is uncertain, the CT scan acts as a powerful tie-breaker, providing decisive clarity that shifts clinical decision-making.

Dr. Shah explained the practical application of these findings in a clinical setting, noting that knowing a borderline patient’s precise calcium score allows physicians to determine whether their true physiological risk is significantly lower or higher than initially estimated. If a patient with a borderline PREVENT score receives a calcium score of zero, their actual risk of a near-term cardiovascular event drops substantially, potentially sparing them from years of preventative medication. Conversely, a unexpectedly high calcium score in a borderline patient serves as an urgent red flag, signaling that aggressive preventative interventions are necessary despite otherwise unremarkable standard blood panels.

The Downsides of Indiscriminate Screening

The findings published in JAMA carry profound implications for clinical guidelines, healthcare economics, and patient safety, underscoring the potential hazards of indiscriminate or routine medical testing. Dr. Shah and his co-authors cautioned against the growing trend of utilizing calcium scans as a universal screening tool for every demographic group, highlighting distinct clinical downsides when scans are ordered outside of appropriate risk parameters.

For individuals evaluated as low-risk by standard tools like PREVENT, ordering a routine calcium scan introduces unnecessary medical complications. These include low-level ionizing radiation exposure from the CT scan, incidental findings that trigger a cascade of secondary diagnostic tests, and direct financial costs for patients and healthcare systems alike—all without delivering clear, actionable clinical benefits. Because low-risk individuals have a negligible probability of experiencing a cardiac event in the near term, a calcium scan is exceptionally unlikely to alter their immediate treatment plan.

Conversely, for individuals already classified as high-risk based on traditional biomarkers, such as severe chronic hypertension or markedly elevated low-density lipoprotein (LDL) cholesterol, a calcium scan is largely redundant. Current medical guidelines strongly recommend that high-risk individuals initiate statin therapy to lower cholesterol and mitigate cardiovascular danger regardless of what an anatomical scan reveals. Therefore, ordering a calcium scan for a high-risk patient introduces unnecessary costs and delays without changing the ultimate therapeutic prescription.

"The findings help us understand how best to use the available tools to estimate someone’s risk of a heart attack or stroke," Dr. Shah stated. "That provides more precise guidance for who is most likely to benefit from using a statin to help prevent heart disease."

Broader Implications for Preventive Cardiology and Healthcare Policy

The publication of this Northwestern Medicine study arrives at a critical juncture for preventive cardiology. As healthcare systems increasingly emphasize value-based care, resource allocation, and personalized medicine, studies that define the boundaries of diagnostic utility are vital.

The validation of the PREVENT calculator as a robust, highly capable standalone tool is another notable takeaway from the research. Even without the expensive and time-consuming addition of imaging diagnostics, PREVENT demonstrated strong predictive power across the diverse MESA cohort. This reinforces the foundational importance of routine primary care screenings, where blood pressure cuffs, standard blood draws, and basic patient histories remain extraordinarily effective at capturing cardiovascular risk.

Furthermore, the study sheds light on the economic dimensions of modern cardiology. With coronary artery calcium scans frequently marketed directly to consumers as out-of-pocket wellness checks, patients are often left to navigate the clinical utility of these tests independently. By establishing clear empirical boundaries—demonstrating that scans are most impactful for the 3 percent to 9 percent borderline risk bracket—the Northwestern research offers a vital roadmap for patients and primary care physicians seeking to maximize health outcomes while avoiding medical overutilization.

Future Directions and Unanswered Questions

While the findings provide immediate clarity, the authors of the study emphasized that further research is required to refine risk prediction models across specific demographic and ethnic populations.

The current study was based on data from the MESA cohort, which, while ethnically diverse, possessed specific age parameters ranging from 45 to 79 years old at baseline. Dr. Shah noted that additional studies are urgently needed to evaluate how calcium scores integrate with PREVENT estimates in higher-risk demographic groups that may experience cardiovascular disease differently, such as South Asian and Filipino adults. Additionally, expanding this line of inquiry to younger cohorts will be essential as early-onset cardiovascular risk factors become more prevalent in modern society.

The research team behind the study includes a prominent roster of Northwestern academics and clinicians, featuring Xiaoning Huang, Lucia Petito, Norrina Allen, Dr. Philip Greenland, and Dr. Sadiya Khan. Financial support for the research was provided by prestigious grants from the American Heart Association (grant 24CDA1266732) and multiple cooperative agreements and contracts from the National Heart, Lung, and Blood Institute.

As the medical community digests the implications of the JAMA publication, the overarching message for patients and physicians is one of strategic precision. Rather than adopting a blanket approach to cardiac imaging, modern preventive cardiology is moving toward a targeted model where advanced diagnostics are deployed precisely where they can alter the course of patient care—transforming borderline uncertainty into actionable, life-saving prevention.